Methods Data of 39 patients with severe ARDS managed with ECMO in two tertiary centers
between 2012 and 2018 were retrospectively studied. Results The mean age of the patient …

Background No definitive conclusions have been drawn from the available data about the
utilization of extracorporeal membrane oxygenation (ECMO) to treat severe acute respiratory …

Background The efficacy of venovenous extracorporeal membrane oxygenation (ECMO) in
patients with severe acute respiratory distress syndrome (ARDS) remains controversial …

Background Case series have reported favorable outcomes with extracorporeal membrane
oxygenation (ECMO) in patients with severe acute respiratory distress syndrome. However …

Background COVID‐19 can lead to acute respiratory distress syndrome (ARDS).
Extracorporeal membrane oxygenation (ECMO) is considered to be a salvage strategy for …

Objectives: Over the last decade, extracorporeal membrane oxygenation (ECMO) has
become a promising option for patients with severe acute respiratory distress syndrome …

The high mortality rate of patients with severe acute respiratory distress syndrome (ARDS)
warrants aggressive clinical intervention. Extracorporeal membrane oxygenation (ECMO) is …

Background: Although the use of extra-corporeal membrane oxygenation (ECMO) has been
rapidly increasing, the benefit of ECMO in patients with acute respiratory distress syndrome …

The use of extracorporeal membrane oxygenation (ECMO) in severe acute respiratory
distress syndrome (ARDS) has increased considerably over the last several years …

Purpose To assess the effect of venovenous extracorporeal membrane oxygenation (ECMO)
compared to conventional management in patients with severe acute respiratory distress …